Dc Investments Management, LLC Beam Therapeutics Inc. Transaction History

Dc Investments Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$53.73 - $82.16 $1.13 Million - $1.73 Million	-21,010 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$71.28 - $120.75 $4.78 Million - $8.1 Million	-67,090 Reduced 76.15%	21,010 $1.68 Million
Q1 2020 May 11, 2020	BUY	$13.31 - $29.2 $1.17 Million - $2.57 Million	88,100 New	88,100 $1.59 Million

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $2.04B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Dc Investments Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Dc Investments Management, LLC with notifications on news.